Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Cognito Therapeutics Raises $73M Series B

2023-03-22
CAMBRIDGE, MA, Cognito Therapeutics announces $73M Series B financing round led by FoundersX Ventures.
Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced a $73M Series B financing round led by FoundersX Ventures with participation from all existing investors. New investors Alzheimer's Drug Discovery Foundation (ADDF), Starbloom Capital, IAG Capital and WS Investment Company (Wilson Sonsini's venture arm) joined the round. The Series B funding brings the total amount raised since inception to $93 million.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors